Gene Synthesis Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
One of the key reasons anticipated to drive the growth of
the global gene synthesis market is the increase in investment in gene
synthesis. The shortage of highly qualified employees and drawn-out approval
procedures may impede market expansion during the projection period. However,
developments that might propel the global gene synthesis market include the
rising use of gene synthesis in the creation of personalised medicine.
Current advancements in synthetic DNA technology are
becoming more and more well-liked as a practical response to worries about the
succession of an increasing number of infections and risks from a worldwide
pandemic, such the COVID-19. The emergence of novel COVID-19 strains and the
increasing use of targeted therapy are driving up the demand for cutting-edge
technologies like gene synthesis to help characterise important genes.
Additionally, a lot of research and development organisations are starting to
use gene synthesis techniques to create extremely precise diagnostics for new diseases.
In order to help medical testing providers create more
precise and dependable diagnostic tests for the condition, the National
Institute of Standards and Technology (NIST) has announced adopting gene
synthesis techniques for creating new synthetic gene segments from the COVID-19
virus. Numerous such developments are predicted to support market expansion.
The gene
synthesis market can be divided into two categories based on the kind
of product: bespoke and gene library synthesis. Market participants offer a
range of services related to gene synthesis, including DNA isolation,
sequencing, library preparation, data analysis, and biological interpretation
of the results in an understandable format. Numerous businesses provide
services. For instance, Novogene offers a variety of services for gene
synthesis for various sample types. On the other hand, Eurofins Genomics is the
first service provider in Europe to offer gene synthesis services using the
Roche/454 GS20.
Comments
Post a Comment